万泰生物获批男性九价HPV疫苗临床试验

财中社11-18 17:35

财中社11月18日电万泰生物（603392）发布关于公司九价HPV疫苗男性临床试验申请获得药物临床试验批准通知书的公告。公司全资子公司厦门万泰沧海生物技术有限公司近日收到国家药监局下发的通知书，批准开展九价人乳头瘤病毒疫苗针对男性人群的临床试验。九价HPV疫苗覆盖七种高危型和两种低危型，适用于预防由相关HPV型所致的多种癌症及其癌前病变。全球每年约有70,000例新发癌症病例与HPV感染相关，尤其...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2484494116?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-18 17:35","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2484494116","market":"sh","top_or_hot":-1,"title":"万泰生物获批男性九价HPV疫苗临床试验","media":"财中社","content":"<div>\n<p>财中社11月18日电万泰生物（603392）发布关于公司九价HPV疫苗男性临床试验申请获得药物临床试验批准通知书的公告。公司全资子公司厦门万泰沧海生物技术有限公司近日收到国家药监局下发的通知书，批准开展九价人乳头瘤病毒疫苗针对男性人群的临床试验。九价HPV疫苗覆盖七种高危型和两种低危型，适用于预防由相关HPV型所致的多种癌症及其癌前病变。全球每年约有70,000例新发癌症病例与HPV感染相关，尤其...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118174932a242aa77&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>万泰生物获批男性九价HPV疫苗临床试验</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n万泰生物获批男性九价HPV疫苗临床试验\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-18 17:35 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118174932a242aa77&s=b><strong>财中社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>财中社11月18日电万泰生物（603392）发布关于公司九价HPV疫苗男性临床试验申请获得药物临床试验批准通知书的公告。公司全资子公司厦门万泰沧海生物技术有限公司近日收到国家药监局下发的通知书，批准开展九价人乳头瘤病毒疫苗针对男性人群的临床试验。九价HPV疫苗覆盖七种高危型和两种低危型，适用于预防由相关HPV型所致的多种癌症及其癌前病变。全球每年约有70,000例新发癌症病例与HPV感染相关，尤其...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118174932a242aa77&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"603392","symbol_name":"万泰生物","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118174932a242aa77&s=b","article_id":"2484494116","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118174932a242aa77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2484494116","pubTimestamp":1731922505,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"财中社11月18日电万泰生物 发布关于公司九价HPV疫苗男性临床试验申请获得药物临床试验批准通知书的公告。公司全资子公司厦门万泰沧海生物技术有限公司近日收到国家药监局下发的通知书，批准开展九价人乳头瘤病毒疫苗针对男性人群的临床试验。九价HPV疫苗覆盖七种高危型和两种低危型，适用于预防由相关HPV型所致的多种癌症及其癌前病变。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159646":"疫苗","603392":"万泰生物","BK0239":"医药制造"},"translate_title":"Wantai Biotech approved for clinical trial of male nine-valent HPV vaccine","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159646":1,"603392":1},"content_text":"财中社11月18日电万泰生物（603392）发布关于公司九价HPV疫苗男性临床试验申请获得药物临床试验批准通知书的公告。公司全资子公司厦门万泰沧海生物技术有限公司近日收到国家药监局下发的通知书，批准开展九价人乳头瘤病毒疫苗针对男性人群的临床试验。九价HPV疫苗覆盖七种高危型和两种低危型，适用于预防由相关HPV型所致的多种癌症及其癌前病变。全球每年约有70,000例新发癌症病例与HPV感染相关，尤其是阴茎癌、肛门癌等。公司研发的疫苗有助于应对这一公共健康问题。公告中还提到，国内已有其他公司提交了男性人群适应症的上市申请，市场竞争环境将对后续销售情况产生影响。2024年前三季度，万泰生物实现收入19.48亿元，归母净利润2.67亿元。文章来源：财中社原标题：万泰生物获批男性九价HPV疫苗临床试验","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"Product Release","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2484494116"}